Skip to main content
. 2023 Jul 17;13:11527. doi: 10.1038/s41598-023-38765-8

Table 2.

Clinical patient characteristics.

Variable All Survivors Non-survivors P value
(n = 816) (n = 593, 72.7%) (n = 223, 27.3%)
Prognostic scores
 APACHE II, median (IQR) 21 (16–28) 20 (15–26) 25 (19–31)  < 0.001
 SOFA, median (IQR) 10 (7–13) 9 (7–12) 12 (8–14)  < 0.001
 SAPS II, median (IQR) 48 (37–62) 45 (35–58) 56 (45–71)  < 0.001
Initial vital signs
 Glasgow Coma Scale, median (IQR) 11 (6–14) 11 (6–14) 10 (6–14) 0.523
 Initial SBP (mmHg), median (IQR) 122.0 (102.0–146.0) 126.0 (108.0–151.0) 110.0 (91.0–132.0)  < 0.001
 Initial DBP (mmHg), median (IQR) 64.0 (54.0–75.2) 65.0 (54.0–77.0) 61.0 (50.0–71.5)  < 0.001
 Initial MBP, median (IQR) 84.3 (70.7–98.0) 86.7 (73.3–100.7) 78.7 (62.8–89.3)  < 0.001
 Initial PR (beats/minute), median (IQR) 104.0 (86.0–120.0) 102.0 (84.0–117.0) 112.0 (94.0–130.0)  < 0.001
 Initial RR (breaths/minute), median (IQR) 22.0 (19.0–27.0) 22.0 (18.0–26.0) 24.0 (20.0–28.0)  < 0.001
 Body temperature (°C), mean (SD) 36.9 (1.1) 36.8 (1.1) 37.0 (1.2) 0.100
 Urine output (ml/hour), mean (SD) 66.0 (52.6) 73.0 (55.1) 47.3 (39.5)  < 0.001
Laboratory findings
 pH, median (IQR) 7.4 (7.3–7.5) 7.4 (7.3–7.4) 7.4 (7.2–7.5) 0.095
 pCO2 (mmHg), median (IQR) 35.3 (29.2–43.7) 35.9 (29.6–43.3) 33.4 (27.6–45.3) 0.122
 PaO2 (mmHg), median (IQR) 68.3 (54.0–85.7) 70.7 (55.6–88.5) 63.2 (51.5–76.5)  < 0.001
 HCO3- (mEq/L), median (IQR) 21.0 (17.1–24.7) 21.7 (17.9–25.3) 19.6 (15.4–22.9)  < 0.001
 Initial SpO2, median (IQR) 95.0 (90.0–98.0) 96.0 (92.0–98.0) 93.0 (87.2–97.0)  < 0.001
 PaO2/FiO2 ratio, median (IQR) 121.6 (78.3–194.0) 139.7 (88.6–212.4) 85.7 (63.3–127.0)  < 0.001
 White blood cell (103/μL), median (IQR) 11.2 (7.6–16.3) 11.1 (7.6–15.5) 12.0 (7.5–18.7) 0.148
 Neutrophil (103/μL), median (IQR) 84.0 (75.9–89.2) 84.0 (76.0–89.4) 84.1 (75.5–88.8) 0.665
 Lymphocyte (103/μL), median (IQR) 10.1 (6.6–16.0) 10.2 (6.9–15.8) 9.9 (6.0–16.2) 0.274
 Hemoglobin, median (IQR) 10.9 (9.2–12.5) 11.1 (9.4–12.6) 10.6 (8.9–11.9) 0.003
 Platelet (103/μL), median (IQR) 205.0 (134.0–294.2) 209.0 (149.0–301.0) 187.0 (96.0–279.5) 0.003
 Lactate (mmol/L), mean (SD) 4.3 (5.2) 3.6 (4.1) 6.1 (6.8)  < 0.001
 C-reactive protein (mg/L), median (IQR) 13.4 (5.8–22.0) 11.8 (4.8–20.8) 17.2 (10.2–24.0)  < 0.001
 Procalcitonin (ng/mL), mean (SD) 2.4 (7.7) 2.3 (8.4) 2.7 (5.2) 0.706
 BUN (mg/dL), median (IQR) 27.0 (15.0–44.0) 26.0 (15.0–42.0) 29.0 (17.0–51.5) 0.031
 Creatinine (mg/dL), median (IQR) 1.2 (0.8–2.1) 1.1 (0.8–1.9) 1.4 (0.9–2.3) 0.006
 Na (mEq/L), median (IQR) 136.0 (132.2–139.8) 136.2 (132.8–139.9) 135.1 (131.2–139.1) 0.027
 K (mEq/L), median (IQR) 4.1 (3.6–4.7) 4.1 (3.6–4.6) 4.1 (3.5–4.7) 0.986
 TCO2 (mEq/L), mean (SD) 20.1 (6.6) 20.4 (6.5) 19.3 (6.6) 0.034
 AST (U/L), median (IQR) 39.0 (26.0–74.0) 37.0 (25.0–70.0) 45.0 (28.0–91.0) 0.005
 ALT (U/L), median (IQR) 20.0 (12.0–38.0) 20.0 (11.0–37.0) 19.0 (12.0–38.5) 0.914
 Total bilirubin (mg/dL), median (IQR) 0.8 (0.6–1.4) 0.8 (0.6–1.4) 0.9 (0.6–1.5) 0.024
 ALP (IU/L), median (IQR) 95.0 (71.8–132.0) 93.0 (71.0–125.0) 100.0 (76.0–148.0) 0.002
 PT INR, median (IQR) 1.2 (1.1–1.4) 1.2 (1.1–1.4) 1.3 (1.2–1.5)  < 0.001
 Troponin I (µg/L), mean (SD) 62.3 (570.2) 56.5 (598.6) 77.8 (485.9) 0.649
 NT-proBNP, mean (SD) 7597.3 (10,760.1) 7527.8 (10,898.5) 7751.6 (10,445.0) 0.817
Treatment
 Steroid, n (%) 564 (69.1%) 385 (64.9%) 179 (80.3%)  < 0.001
 Vasopressor, n (%) 353 (43.3%) 195 (32.9%) 158 (70.9%)  < 0.001

APACHE, Acute Physiology and Chronic Health Evaluation; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; DBP, diastolic blood pressure; MBP, mean blood pressure; PR, pulse rate; RR, respiratory rate; SBP, systolic blood pressure; NT-proBNP, n-terminal prohormone brain natriuretic peptide; PT INR, international normalized ratio of prothrombin time; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment.